SCHEMBL4654201

SCHEMBL4654201

CON(C)C(=O)c1sc2cc(F)ccc2c1C

nearest known ligand 0.46

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
TRPM8 Q7Z2W7 2/20 0.46
BCKDK O14874 1/20 0.46
CLK1 P49759 2/20 0.42
DYRK1A Q13627 2/20 0.42
DYRK1B Q9Y463 2/20 0.42
RAB9A P51151 2/20 0.41
KDM4E B2RXH2 1/20 0.41
CES2 O00748 1/20 0.41
PTGS1 P23219 1/20 0.40
MAOB P27338 1/20 0.40
CASP3 P42574 1/20 0.40
GPER1 Q99527 1/20 0.40
NPC1 O15118 1/20 0.38
TP53 P04637 1/20 0.38
SMN1; SMN2 Q16637 1/20 0.38
SENP1 Q9P0U3 1/20 0.37
ESR1 P03372 2/20 0.37
GPR35 Q9HC97 1/20 0.36
ICAM1 P05362 1/20 0.36
SELE P16581 1/20 0.36

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28957388 0.85 BCKDK (0.62) TRPM8BCKDKDYRK1ARAB9AKDM4E
SCHEMBL4654240 0.85 CES2 (0.56) CLK1DYRK1ADYRK1BRAB9AKDM4E
SCHEMBL4654293 0.83 MLYCD (0.42) TRPM8CLK1DYRK1ADYRK1BCES2
SCHEMBL4654000 0.80 BCKDK (0.50) BCKDKRAB9AKDM4ECES2PTGS1
SCHEMBL2895162 0.78 BCKDK (0.67) BCKDKRAB9AKDM4ECES2PTGS1
SCHEMBL4656300 0.75 DYRK1A (0.42) TRPM8CLK1DYRK1ADYRK1BTP53
SCHEMBL159986 0.72 CLK1 (0.60) TRPM8CLK1DYRK1ADYRK1BICAM1
SCHEMBL2588929 0.71 RAD52 (0.53) TRPM8DYRK1AKDM4EMAOBSMN1; SMN2
SCHEMBL716858 0.71 KDM4E (0.48) RAB9AKDM4EMAOBNPC1SMN1; SMN2
SCHEMBL31081144 0.71 STING1 (0.39) TRPM8CLK1DYRK1ADYRK1BCES2

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 4 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-1740568-B1 BENZOFURAN AND BENZOTHIOPHENE DERIVATIVES USEFUL FOR THE TREATMENT OF CARDIOVASCULAR DISEASE. SMITHKLINE BEECHAM CORP (US) 2008-11-26 EP disclosed
US-20070155805-A1 Benzofuran and bezothiophene derivatives useful for the treatment of cardiovascular disease SMITHKLINE BEECHAM CORPORATION 2007-07-05 US disclosed
US-20070155805-A1 Benzofuran and bezothiophene derivatives useful for the treatment of cardiovascular disease SMITHKLINE BEECHAM CORPORATION 2007-07-05 US disclosed
US-20070155805-A1 Benzofuran and bezothiophene derivatives useful for the treatment of cardiovascular disease SMITHKLINE BEECHAM CORPORATION 2007-07-05 US disclosed

Patent text — is the patent's own abstract consistent with the prediction?

For each of this compound's patents that has machine-readable text (1 of them — usually the abstract, not the full specification), we ask MedCPT which protein the text reads most about, and where the chemistry-predicted target lands among 4885 human targets. A high rank means the patent's own wording is consistent with the prediction — a weak, independent signal, not proof of activity.

PatentTitleText reads most aboutPredicted target · text-rank
US-20070155805-A1 Benzofuran and bezothiophene derivatives useful for the treatment of cardiovascular disease ABAT, BPTF, TNNT2 TRPM8 2928/4885BCKDK 62/4885CLK1 4746/4885

“Text reads most about” is the patent abstract's nearest protein in MedCPT space (background-debiased). Only ~1.4% of patents have machine-readable text, so most compounds won't have this panel.